GlucaPen® is not yet approved and is still in development.
See our "News & Press" page for articles.
We've finished the prototype and are working with the FDA on development of testing requirements. GlucaPen® will inject glucagon to treat Severe Hypoglycemia (SH)...a potentially life threatening medical
emergency that occurs in insulin using Type 1 and Type 2 diabetics.
On this web site you will be able to learn more about severe
hypoglycemia, our solution GlucaPen®and the team responsible for its
development.Please contact us with any questions,
comments or suggestions.
If you want to be kept updated on the latest
developments on GlucaPen® please visit our
News and Press page and
sign-up for our newsletter.